SHAKEVIA JOHNSON: Open Payments
NPI 1104236850 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $123 |
| Alkermes, Inc. | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 1 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: LYBALVI, UZEDY, ABILIFY ASIMTUFII, Auvelity, COBENFY, CAPLYTA.
Industry payments across MA — which companies pay providers there.
